1. Nass SJ, Henderson IC, Lashof JC, National Cancer Policy Board (U.S.). Committee on Technologies for the Early Detection of Breast Cancer., National Cancer Policy Board (U.S.). Committee on the Early Detection of Breast Cancer: Mammography and beyond: Developing technologies for the early detection of breast cancer. National Academy Press, Washington, DC, 2001
2. Curry SJ, Byers T, Hewitt M: Fulfilling the potential of cancer prevention and early detection: National Academies Press, 1 edition. (May 21, 2003), 2003
3. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317–1325, 2004
4. Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Thompson D, Warren RM: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778, 2005
5. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437, 2004